Trial Details

TERMINATED
Basic Information
Clinical ID c94
Identifier NCT03370601
Trial Title Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases
Interventions DRUG: Infliximab|DRUG: Mercaptopurine|DRUG: Azathioprine|DRUG: Infliximab
Participant Information
Sponsor University Hospital, Lille
City Lille
Country/Region France
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase -
Time Information
Start Date 2017-01-03
Primary Completion Date 2025-01-19
Completion Date 2025-01-19